Navigation Links
InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
Date:10/28/2008

BRITISH COLUMBIA, Canada, Oct. 28 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces that Jeff Morhet, CEO and Chairman, will present at the 7th Annual BIO Investor Forum on October 30, 2008.

Mr. Morhet's thirty-minute presentation to potential investors and industry partners will begin at 3:15PM within the Twin Peaks South Room of the Palace Hotel in San Francisco, California. He will provide a company overview, including information about InNexus' unique business strategy, its DXL(TM) technology platform, recent partnerships and company milestones.

The 7th Annual BIO Investor Forum will be held October 29-31, 2008 at the Palace Hotel in San Francisco, California. The BIO Investor Forum is held every year to bring late-stage private and emerging public biotech companies and investors together to meet and attend roundtables, panel discussions and seminars on a variety of biotechnology topics.

About InNexus

InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL(TM) technology, which improves the potency of existing antibody products while opening new markets and disease applications. DXL(TM) antibodies utilize unique, novel and patented methods and technologies of InNexus.

InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit

SOURCE InNexus Biotechnology Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
2. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
3. InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC
4. InNexus Biotechnology Strengthens Patent Team With New Leadership
5. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
6. InNexus Biotechnology CEO to Present at BioContactQuebec 2008
7. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
8. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
9. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
10. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
11. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:1/22/2015)...  Derma Sciences, Inc. (Nasdaq: DSCI ), ... care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts ... the Premier, Inc. Regenerative Skin Grafting contract portfolio. ... and AMNIOMATRIX® product lines, which continue to be ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, ... in critical areas, announced the closing of an underwritten public ... purchase up to an aggregate 3,500,000 shares of common stock, ... per warrant.  The warrants have a per share exercise price ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... L. Urdal, Dendreon Corporation, Joins Board of Directors, Ron ... Myers Appointed Vice President Legal Affairs ... Seattle-based,biotechnology company focused on the development of therapeutics for,autoimmune ... L. Urdal, chief scientific officer of Dendreon Corporation,(Nasdaq: ...
... Md., Feb. 13 Lentigen Corporation today,announced ... and,manufacturing facilities from the University of Maryland ... facility in Gaithersburg., Located along Maryland,s ... Lentigen,s future growth needs as a leading,developer ...
... ATLANTA, Feb. 13 CryoLife, Inc. (NYSE: CRY ... that it is scheduled to participate in the Roth ... 2008 at the Ritz Carlton,Laguna Niguel in Dana Point, ... operating officer and,chief financial officer of CryoLife, Inc., will ...
Cached Biology Technology:VLST Corporation Announces Board and Executive Management Appointments 2VLST Corporation Announces Board and Executive Management Appointments 3Lentigen to Move Headquarters and Manufacturing to Gaithersburg 2CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference 2
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the ... Security Systems Market" report to their offering. ... perimeter security market is estimated to grow at a CAGR ... holds a larger share in this market, Canada ...
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced today its ... confirm its adherence to current U.S. Food and Drug ... regulated smart device and smart phone application trials utilizing ... "HITLAB is determined to improve global healthcare ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Science annual survey of Top ... and related industries. Respondents to the web-based ... 23 driving characteristics, including financial strength, easy adaptation ... year, Genentech, Inc., of South San Francisco, California, ...
... Good news for procrastinating students: a nasal spray developed ... night cram sessions a major boost, if a good night,s ... story of the October 2009 print issue of The ... a molecule from the body,s immune system (interleukin-6) when administered ...
... Entomological Society of America (ESA) is presenting the Editor,s Choice ... the ESA journals and from American Entomologist magazine. ... ESA Annual Meeting in December (co-authors will split the prize). ... editors of each publication, are as follows: ...
Cached Biology News:Best rntomology srticles in 2008 2Best rntomology srticles in 2008 3
Insect Cell Lysis Buffer 50 ml...
Rabbit polyclonal to Orexin Prepro ( Abpromise for all tested applications). entrezGeneID: 3060 SwissProtID: O43612...
AK6 Antibody...
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
Biology Products: